Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c

Christopher P. Cannon; Vlado Perkovic; Rajiv Agarwal; James Baldassarre; George Bakris; David M. Charytan; Dick de Zeeuw; Robert Edwards; Tom Greene; Hiddo J. L. Heerspink; Meg J. Jardine; Adeera Levin; Jing-Wei Li; Bruce Neal; Carol Pollock; David C. Wheeler; Hong Zhang; Bernard Zinman; Kenneth W. Mahaffey

doi:10.1161/CIRCULATIONAHA.119.044359

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c

Christopher P. Cannon^*, Vlado Perkovic, Rajiv Agarwal, James Baldassarre, George Bakris, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J. L. Heerspink, Meg J. Jardine, Adeera Levin, Jing-Wei Li, Bruce Neal, Carol Pollock, David C. Wheeler, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

106 Citaten (Scopus)

70 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	407-410
Aantal pagina's	4
Tijdschrift	Circulation
Volume	141
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1161/CIRCULATIONAHA.119.044359
Status	Published - 4-feb.-2020

Toegang tot document

10.1161/CIRCULATIONAHA.119.044359Licentie: CC BY

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%Final publisher's version, 167 KBLicentie: CC BY

Handle.net

Permanente koppeling

Citeer dit

Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., Jardine, M. J., Levin, A., Li, J.-W., Neal, B., Pollock, C., Wheeler, D. C., Zhang, H., Zinman, B., & Mahaffey, K. W. (2020). Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c. Circulation, 141(5), 407-410. https://doi.org/10.1161/CIRCULATIONAHA.119.044359

@article{2a905f3f034d42858dff357440774ddb,

title = "Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c",

keywords = "canagliflozin, chronic kidney disease, diabetes mellitus, type 2, SGLT2 inhibitors",

author = "Cannon, {Christopher P.} and Vlado Perkovic and Rajiv Agarwal and James Baldassarre and George Bakris and Charytan, {David M.} and {de Zeeuw}, Dick and Robert Edwards and Tom Greene and Heerspink, {Hiddo J. L.} and Jardine, {Meg J.} and Adeera Levin and Jing-Wei Li and Bruce Neal and Carol Pollock and Wheeler, {David C.} and Hong Zhang and Bernard Zinman and Mahaffey, {Kenneth W.}",

year = "2020",

month = feb,

day = "4",

doi = "10.1161/CIRCULATIONAHA.119.044359",

language = "English",

volume = "141",

pages = "407--410",

journal = "Circulation",

issn = "0009-7322",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "5",

}

Cannon, CP, Perkovic, V, Agarwal, R, Baldassarre, J, Bakris, G, Charytan, DM, de Zeeuw, D, Edwards, R, Greene, T, Heerspink, HJL, Jardine, MJ, Levin, A, Li, J-W, Neal, B, Pollock, C, Wheeler, DC, Zhang, H, Zinman, B & Mahaffey, KW 2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c', Circulation, vol. 141, nr. 5, blz. 407-410. https://doi.org/10.1161/CIRCULATIONAHA.119.044359

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c. / Cannon, Christopher P.; Perkovic, Vlado; Agarwal, Rajiv et al.
In: Circulation, Vol. 141, Nr. 5, 04.02.2020, blz. 407-410.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c

AU - Cannon, Christopher P.

AU - Perkovic, Vlado

AU - Agarwal, Rajiv

AU - Baldassarre, James

AU - Bakris, George

AU - Charytan, David M.

AU - de Zeeuw, Dick

AU - Edwards, Robert

AU - Greene, Tom

AU - Heerspink, Hiddo J. L.

AU - Jardine, Meg J.

AU - Levin, Adeera

AU - Li, Jing-Wei

AU - Neal, Bruce

AU - Pollock, Carol

AU - Wheeler, David C.

AU - Zhang, Hong

AU - Zinman, Bernard

AU - Mahaffey, Kenneth W.

PY - 2020/2/4

Y1 - 2020/2/4

KW - canagliflozin

KW - chronic kidney disease

KW - diabetes mellitus, type 2

KW - SGLT2 inhibitors

U2 - 10.1161/CIRCULATIONAHA.119.044359

DO - 10.1161/CIRCULATIONAHA.119.044359

M3 - Letter

SN - 0009-7322

VL - 141

SP - 407

EP - 410

JO - Circulation

JF - Circulation

IS - 5

ER -